Cargando…
A novel nucleolin-binding peptide for Cancer Theranostics
Background: Cancer-specific ligands have been of great interest as pharmaceutical carriers due to the potential for site-specific delivery. In particular, cancer-specific peptides have many advantages over nanoparticles and antibodies, including high biocompatibility, low immunogenicity, and the for...
Autores principales: | Kim, Jae-Hyun, Bae, Chanhyung, Kim, Min-Jung, Song, In-Hye, Ryu, Jae-Ha, Choi, Jang-Hyun, Lee, Choong-Jae, Nam, Jeong-Seok, Kim, Jae Il |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415810/ https://www.ncbi.nlm.nih.gov/pubmed/32802184 http://dx.doi.org/10.7150/thno.43502 |
Ejemplares similares
-
Solution Structure of
Kurtoxin: A Gating Modifier
Selective for Cav3 Voltage-Gated Ca(2+) Channels
por: Lee, Chul Won, et al.
Publicado: (2012) -
High Yield Production and Refolding of the Double-Knot Toxin, an Activator of TRPV1 Channels
por: Bae, Chanhyung, et al.
Publicado: (2012) -
Identification of Nucleolin as a Novel AEG-1-Interacting Protein in Breast Cancer via Interactome Profiling
por: Lee, Seong-Jae, et al.
Publicado: (2021) -
Targeted theranostic photoactivation on atherosclerosis
por: Song, Joon Woo, et al.
Publicado: (2021) -
Regulation of the Gene Expression of Airway MUC5AC Mucin through NF-(κ)B Signaling Pathway by Artesunate, an Antimalarial Agent
por: Kim, Kyung-il, et al.
Publicado: (2023)